Nxera Pharma Is A Biopharmaceutical Company Based In Japandedicated To Developing Innovative Medicines Through Advanced Science And Technologythe Company Operates Globallywith A Focus On Drug Discovery And Early Stage Development In The Ukwhile Managing Late Stage Clinical Development And Commercialization In Japan And The Asia Pacific Region Nxera Pharma Specializes In Structure Based Drug Design And Employs Technology Driven Approachesincluding Ai Augmented Drug Discoveryits Capabilities Encompass Proprietary Drug Discovery Platforms For Gpcr Targeted Therapies And Expertise In Clinical Developmentparticularly In Neurology And Metabolic Disordersthe Company Collaborates With Global Pharmaceutical Partners For Co Development And Commercializationenhancing Its Reach In The Market Among Its Approved Products Is Quviviqan Insomnia Treatment Developed In Partnership With Idorsia And Shionogithe Company Also Has A Diverse Pipeline Targeting Various Conditionsincluding Inflammatory Diseases And Neurological Disordersheadquartered In Tokyonxera Pharma Maintains A Strong Operational Presence In The Uk And Partnerships Across The Us And Europe
No conferences found for this company.
| Company Name | Heptares Therapeutics Ltd |
| Country |
United Kingdom
|
| Address | Biopark Broadwater Road Welwyn Garden City Hertfordshire Al7 3ax Uk |
| Telephone | Login to View |
| Login to View |
